Search results for cdkn2b

435 hits were found for cdkn2b

# Family MCID Name MIFTS Score
1
P LNG032 Lung Cancer 98 20.417
2
P GST053 Gastric Cancer 83 19.751
3
P CLR023 Colorectal Cancer 100 18.015
4
GLB002 Glioblastoma 67 17.882
5
P BLD134 Bladder Cancer 79 17.623
6
P MLN066 Melanoma, Cutaneous Malignant 1 66 17.530
7
c MLT156 Multiple Endocrine Neoplasia, Type I 72 17.432
8
P OVR042 Ovarian Cancer 88 17.080
9
P HPT023 Hepatocellular Carcinoma 96 16.698
10
P OPN001 Open-Angle Glaucoma 55 16.607
11
ESP021 Esophageal Cancer 83 16.591
12
P LKM062 Leukemia, Acute Lymphoblastic 69 16.219
13
P LYM118 Lymphoma 67 15.664
14
P MLN008 Melanoma 76 15.416
15
P BCL017 B-Cell Lymphoma 59 15.050
16
MYL009 Myelodysplastic Syndrome 67 14.928
17
P RTN024 Retinoblastoma 73 14.075
18
P PRS040 Prostate Cancer 95 13.889
19
c GLC092 Glaucoma, Primary Open Angle 62 13.831
20
P ADN016 Adenocarcinoma 63 13.831
21
LPP008 Lipoprotein Quantitative Trait Locus 65 13.650
22
HGH043 High Grade Glioma 45 13.486
23
LRY018 Laryngeal Squamous Cell Carcinoma 44 13.434
24
P OLG002 Oligodendroglioma 66 13.408
25
MYC006 Mycosis Fungoides 65 13.228
26
SKN019 Skin Melanoma 71 13.191
27
TCL027 T-Cell Acute Lymphoblastic Leukemia 51 12.972
28
PPL022 Papilloma 53 12.245
29
P DBT009 Diabetes Mellitus 67 12.014
30
c ACT073 Acute Leukemia 58 11.761
31
c TYP009 Type 2 Diabetes Mellitus 92 11.753
32
CHL152 Childhood Acute Lymphocytic Leukemia 50 11.579
33
INT030 Intracranial Aneurysm 55 11.564
34
MNN043 Meningioma, Familial 79 11.492
35
c LKM061 Leukemia, Acute Myeloid 83 11.440
36
ACT119 Acute Promyelocytic Leukemia 62 11.248
37
ANP005 Anaplastic Astrocytoma 57 11.211
38
P MYC007 Myocardial Infarction 70 11.173
39
c MST023 Mesothelioma, Malignant 56 11.128
40
P BLY001 B-Lymphoblastic Leukemia/lymphoma 52 11.076
41
SQM013 Squamous Cell Carcinoma, Head and Neck 73 10.930
42
P MDL005 Medulloblastoma 75 10.792
43
LYM040 Lymphoblastic Lymphoma 53 10.792
44
c ADL052 Adult Acute Lymphocytic Leukemia 46 10.792
45
PRC049 Precursor T-Cell Acute Lymphoblastic Leukemia 45 10.689
46
MNT001 Mantle Cell Lymphoma 67 10.585
47
P RHB003 Rhabdomyosarcoma 66 10.237
48
BRK010 Burkitt Lymphoma 66 9.875
49
P LKM071 Leukemia, Chronic Lymphocytic 75 9.780
50
P ACT008 Actinic Keratosis 54 9.780
51
CHL061 Childhood Leukemia 47 9.780
52
LYM143 Lymphoma, Non-Hodgkin, Familial 75 9.650
53
c BSL007 Basal Cell Carcinoma 68 9.496
54
c LKM063 Leukemia, Chronic Myeloid 71 9.296
55
P LYN001 Lynch Syndrome 76 9.296
56
HMT002 Hematologic Cancer 61 9.296
57
c FML021 Familial Hypercholesterolemia 72 9.296
58
P MYX008 Myxoid Chondrosarcoma 29 8.811
59
P NRV006 Nervous System Cancer 48 8.811
60
MLN070 Melanoma-Astrocytoma Syndrome 33 8.630
61
INT323 Intraocular Pressure Quantitative Trait Locus 64 7.791
62
P LFR001 Li-Fraumeni Syndrome 73 7.786
63
P RTN008 Retinitis Pigmentosa 80 6.231
64
MXD012 Mixed Oligodendroglioma-Astrocytoma 31 6.231
65
RTN015 Retinal Cancer 49 6.231
66
CRN020 Coronary Restenosis 39 6.231
67
c PRM299 Primary Cutaneous B-Cell Lymphoma 37 6.231
68
LWG005 Low-Grade Astrocytoma 38 6.231
69
CRB031 Cerebral Arterial Disease 33 6.231
70
THY009 Thyroid Lymphoma 43 6.231
71
TNS001 Tenosynovial Giant Cell Tumor 40 6.231
72
GLM008 Glomus Tumor 50 6.231
73
VLL005 Vallecula Cancer 25 6.231
74
P LKM002 Leukemia 67 5.824
75
OST159 Osteogenic Sarcoma 66 5.718
76
GLM045 Glioma 63 5.032
77
P MYL006 Myeloid Leukemia 61 4.937
78
SQM006 Squamous Cell Carcinoma 60 4.888
79
ART140 Arteries, Anomalies of 53 4.838
80
P CRN300 Coronary Heart Disease 1 73 4.459
81
P HRT032 Heart Disease 81 4.266
82
GLL048 Glial Tumor 52 4.198
83
ATH013 Atherosclerosis Susceptibility 63 4.155
84
LNG039 Lung Squamous Cell Carcinoma 57 4.152
85
PLM134 Pulmonary Fibrosis, Idiopathic 76 3.579
86
P PLM036 Pulmonary Fibrosis 66 3.579
87
c FBR046 Fibrosis of Extraocular Muscles, Congenital, 1 59 3.483
88
ANR040 Aneurysm 61 3.438
89
P GLM040 Glioma Susceptibility 1 71 3.425
90
P INF037 Inflammatory Bowel Disease 53 3.389
91
P LNG064 Lung Cancer Susceptibility 3 70 3.389
92
RNL114 Renal Cell Carcinoma, Nonpapillary 80 3.320
93
YMN001 Yemenite Deaf-Blind Hypopigmentation Syndrome 66 3.183
94
P PNC035 Pancreatic Cancer 86 3.146
95
STR067 Stroke, Ischemic 80 3.111
96
P NRB001 Neuroblastoma 66 3.102
97
ULC004 Ulcerative Colitis 74 3.102
98
END057 Endometrial Cancer 72 2.988
99
c MCR130 Microvascular Complications of Diabetes 6 41 2.941
100
c MCR120 Microvascular Complications of Diabetes 7 47 2.941
101
c MCR113 Microvascular Complications of Diabetes 3 52 2.941
102
c MCR133 Microvascular Complications of Diabetes 4 41 2.941
103
DFF005 Diffuse Large B-Cell Lymphoma 54 2.885
104
ART016 Aortic Aneurysm 68 2.885
105
c ART138 Aortic Aneurysm, Familial Abdominal, 1 61 2.827
106
P END044 Endometriosis 62 2.642
107
CHL065 Cholangiocarcinoma 58 2.576
108
INT079 Intrahepatic Cholangiocarcinoma 51 2.576
109
PNC041 Pancreatic Ductal Adenocarcinoma 51 2.469
110
LNG099 Lung Disease 62 2.463
111
CNG034 Congestive Heart Failure 69 2.399
112
P KDN017 Kidney Cancer 61 2.399
113
PRT029 Parathyroid Adenoma 51 2.362
114
CRV035 Cervical Cancer 73 2.333
115
CLT003 Colitis 63 2.333
116
CRT013 Carotid Stenosis 51 2.333
117
P BNG032 Benign Mesothelioma 53 2.323
118
P MLT074 Multiple Endocrine Neoplasia 59 2.283
119
SCR001 Secretory Meningioma 40 2.265
120
LYM002 Lymphoplasmacyte-Rich Meningioma 35 2.265
121
SPN021 Spinal Meningioma 50 2.265
122
c WLF013 Wolfram Syndrome 1 60 2.193
123
BLD131 Bladder Urothelial Carcinoma 60 2.193
124
ART074 Aortic Dissection 53 2.119
125
P THR014 Thrombocytopenia 66 2.119
126
c THR001 Thrombocytopenia Due to Platelet Alloimmunization 60 2.119
127
MLG169 Malignant Astrocytoma 57 2.111
128
P VSC007 Vascular Disease 63 2.040
129
HPT022 Hepatoblastoma 54 1.957
130
CRB039 Cerebrovascular Disease 66 1.913
131
P EYD002 Eye Disease 57 1.876
132
AGN016 Aging 54 1.868
133
P FTT008 Fatty Liver Disease, Nonalcoholic 1 48 1.868
134
P CTN015 Cutaneous T Cell Lymphoma 48 1.868
135
NNL005 Non-Alcoholic Fatty Liver Disease 63 1.868
136
P HYP838 Hyperlipidemia, Familial Combined, 3 61 1.868
137
CLL010 Cellular Ependymoma 57 1.868
138
P OPT006 Optic Nerve Disease 58 1.868
139
P BNG030 Benign Ependymoma 51 1.868
140
HRD223 Hereditary Melanoma 37 1.868
141
PRP080 Peripheral Artery Disease 54 1.773
142
c EXS020 Exostoses, Multiple, Type Ii 38 1.773
143
ADN018 Adenoma 59 1.773
144
DYS002 Dysplastic Nevus Syndrome 54 1.773
145
THY029 Thyroid Carcinoma 51 1.746
146
P PRD008 Periodontitis 64 1.678
147
P ANP001 Anaplastic Large Cell Lymphoma 61 1.670
148
P FLL037 Follicular Lymphoma 74 1.670
149
ORL015 Oral Squamous Cell Carcinoma 43 1.670
150
P BNG002 Benign Meningioma 36 1.670
151
ANP009 Anaplastic Oligodendroglioma 41 1.670
152
ORL011 Oral Cancer 60 1.670
153
ANP008 Anaplastic Oligoastrocytoma 29 1.670
154
OLG006 Oligoastrocytoma 34 1.670
155
ADN011 Adenoid Cystic Carcinoma 68 1.652
156
ISC004 Ischemia 61 1.606
157
CLR108 Colorectal Adenoma 64 1.585
158
P BRS047 Breast Cancer 98 1.565
159
HLC007 Helicobacter Pylori Infection 67 1.556
160
c LFR007 Li-Fraumeni Syndrome 2 46 1.556
161
PLM020 Pleomorphic Xanthoastrocytoma 40 1.556
162
48X005 48,xyyy 39 1.556
163
CHR072 Chordoma 57 1.504
164
MLG079 Malignant Pleural Mesothelioma 42 1.462
165
SQM002 Squamous Cell Papilloma 46 1.453
166
P NRF002 Neurofibromatosis 57 1.453
167
P TMR010 Tumor Predisposition Syndrome 67 1.428
168
CRD132 Cardiac Conduction Defect 60 1.426
169
P ZNC008 Zinc Finger Protein 1 23 1.426
170
c LNG109 Lung Cancer Susceptibility 1 26 1.426
171
INT007 Intermediate Coronary Syndrome 54 1.426
172
P TRT010 Teratoma 51 1.426
173
CLN015 Colon Adenocarcinoma 65 1.415
174
GST040 Gastric Adenocarcinoma 67 1.406
175
GLC084 Glaucoma, Normal Tension 45 1.272
176
c MLN067 Melanoma, Cutaneous Malignant 2 29 1.272
177
c GLM020 Glioma Susceptibility 5 11 1.272
178
ACT088 Acute Insulin Response 39 1.272
179
c GLM021 Glioma Susceptibility 6 11 1.272
180
SPN035 Spindle Cell Sarcoma 54 1.272
181
SRC014 Sarcoma 65 1.272
182
P NSP012 Nasopharyngeal Carcinoma 61 1.186
183
MYL069 Myeloma, Multiple 77 1.186
184
THY111 Thyroid Carcinoma, Familial Medullary 67 1.186
185
THY125 Thyroid Gland Medullary Carcinoma 48 1.186
186
GST033 Gestational Diabetes 61 1.186
187
NRF007 Neurofibroma 64 1.186
188
CHR178 Chromosomal Triplication 34 1.186
189
c CRN173 Coronary Heart Disease 8 13 1.083
190
P PRS062 Persistent Hyperplastic Primary Vitreous 48 1.083
191
TST014 Testicular Cancer 52 1.083
192
PRM024 Primary Angle-Closure Glaucoma 39 1.083
193
c MCR115 Microvascular Complications of Diabetes 5 65 1.071
194
DDF001 Dedifferentiated Liposarcoma 49 1.071
195
P MYP006 Myopia 56 1.071
196
HYP066 Hyperglycemia 61 1.071
197
MCL006 Macular Retinal Edema 57 1.071
198
P LPS002 Liposarcoma 64 1.071
199
BRR014 Barrett Esophagus 66 1.020
200
GST103 Gastric Cancer, Hereditary Diffuse 68 1.019
201
SML009 Small Intestine Adenocarcinoma 57 1.019
202
P RRT020 Rare Tumor 39 0.969
203
c BDY010 Body Mass Index Quantitative Trait Locus 4 46 0.969
204
c BDY011 Body Mass Index Quantitative Trait Locus 10 45 0.969
205
c BDY005 Body Mass Index Quantitative Trait Locus 9 47 0.969
206
c BDY012 Body Mass Index Quantitative Trait Locus 7 44 0.969
207
P FST017 Fasting Plasma Glucose Level Quantitative Trait Locus 5 12 0.969
208
P BDY004 Body Mass Index Quantitative Trait Locus 11 83 0.969
209
EXF001 Exfoliation Syndrome 56 0.969
210
c BDY006 Body Mass Index Quantitative Trait Locus 8 44 0.969
211
c BDY017 Body Mass Index Quantitative Trait Locus 14 45 0.969
212
c BDY020 Body Mass Index Quantitative Trait Locus 19 52 0.969
213
c BDY015 Body Mass Index Quantitative Trait Locus 12 46 0.969
214
INV006 Inverted Papilloma 49 0.969
215
c BDY019 Body Mass Index Quantitative Trait Locus 18 47 0.969
216
P HYP069 Hyperparathyroidism 62 0.969
217
KRT009 Keratosis 53 0.969
218
c PRM005 Primary Hyperparathyroidism 59 0.969
219
P AGG001 Aggressive Periodontitis 55 0.969
220
DND018 Dendritic Cell Tumor 41 0.969
221
BLS007 Blastic Plasmacytoid Dendritic Cell 38 0.969
222
OVR094 Ovarian Epithelial Cancer 39 0.969
223
c PLY162 Polyposis Syndrome, Hereditary Mixed, 1 60 0.931
224
c CLR087 Colorectal Cancer 12 34 0.931
225
PRP036 Peripheral T-Cell Lymphoma 53 0.863
226
VNH007 Von Hippel-Lindau Syndrome 73 0.839
227
P FML011 Familial Adenomatous Polyposis 71 0.839
228
CNV018 Convulsions, Familial Infantile, with Paroxysmal Choreoathetosis 43 0.839
229
c PRD040 Periodontitis, Chronic 52 0.839
230
GLC003 Glucose Intolerance 54 0.839
231
P HRD001 Hereditary Multiple Exostoses 48 0.839
232
TST004 Testicular Lymphoma 39 0.839
233
UTR056 Uterine Corpus Endometrial Carcinoma 27 0.839
234
ART017 Aortic Disease 49 0.839
235
P INF032 Infertility 57 0.839
236
LPD008 Lipid Metabolism Disorder 62 0.839
237
ADN089 Adenosquamous Lung Carcinoma 49 0.721
238
LYM133 Lymphoma, Hodgkin, Classic 74 0.685
239
RFR007 Refractory Anemia with Excess Blasts in Transformation 26 0.685
240
c FML311 Familial Colorectal Cancer Type X 37 0.685
241
ART141 Arteriovenous Malformations of the Brain 60 0.685
242
c THR092 Thrombophilia Due to Thrombin Defect 74 0.685
243
ANG054 Angina Pectoris 66 0.685
245
SMT018 Smith-Mccort Dysplasia 2 34 0.685
246
c PCH010 Pachyonychia Congenita 3 43 0.685
247
c ANR029 Aneurysm, Intracranial Berry, 6 12 0.685
248
P ART106 Arterial Calcification, Generalized, of Infancy, 1 48 0.685
249
MLT118 Multiple Acyl-Coa Dehydrogenase Deficiency 65 0.685
250
c HYP836 Hypercholesterolemia, Familial, 1 73 0.685
251
c NRF024 Neurofibromatosis, Type I 72 0.685
252
c PRM301 Primary Cutaneous T-Cell Lymphoma 36 0.685
253
47X002 47,xyy 48 0.685
254
SKN016 Skin Disease 63 0.685
255
P PTT006 Pituitary Adenoma 55 0.685
256
PNC129 Pancreatic Adenocarcinoma 65 0.685
257
SRC030 Sarcomatoid Carcinoma 42 0.685
258
MLG077 Malignant Peripheral Nerve Sheath Tumor 54 0.685
259
DFF016 Diffuse Astrocytoma 45 0.685
260
BRN028 Brain Cancer 74 0.685
261
P NTR004 Neutropenia 63 0.685
262
P MLN007 Male Infertility 56 0.685
263
P GRV001 Graves' Disease 55 0.685
264
ACR007 Acromegaly 70 0.685
265
P HYP086 Hypothyroidism 69 0.685
266
P HPT021 Hepatitis 69 0.685
267
GLS001 Gliosarcoma 64 0.685
268
TCL028 T-Cell Lymphoblastic Leukemia/lymphoma 46 0.685
269
ACN001 Acinar Cell Carcinoma 45 0.685
270
P ART005 Arteriovenous Malformation 65 0.685
271
c HPT016 Hepatitis B 62 0.685
272
PLM033 Pulmonary Embolism 58 0.685
273
P INS002 in Situ Carcinoma 53 0.685
274
GST057 Gastro-Enteropancreatic Neuroendocrine Tumor 16 0.685
275
c LKM005 Leukemia, T-Cell, Chronic 34 0.685
276
SPT007 Spitz Nevus 34 0.685
277
c FML053 Familial Colorectal Cancer 48 0.685
278
SML031 Small Cell Carcinoma of the Bladder 46 0.589
279
LNG012 Lung Occult Squamous Cell Carcinoma 20 0.589
280
BRN015 Bronchiolo-Alveolar Adenocarcinoma 55 0.589
281
LNG007 Lung Mixed Small Cell and Squamous Cell Carcinoma 21 0.589
282
c TYP008 Type 1 Diabetes Mellitus 70 0.484
283
c FML353 Familial Ovarian Cancer 32 0.484
284
RFR010 Refractory Anemia 49 0.484
285
PLS037 Plasma Cell Tumor 20 0.484
286
c NRF023 Neurofibromatosis, Type Ii 71 0.484
287
SPP011 Suppression of Tumorigenicity 12 61 0.484
288
P TST021 Testicular Germ Cell Tumor 61 0.484
289
P ART067 Aortic Aneurysm, Familial Thoracic 1 61 0.484
290
ALL003 Allergic Rhinitis 67 0.484
291
c LKM070 Leukemia, Acute Monocytic 56 0.484
292
c PRD039 Periodontitis, Aggressive, 1 47 0.484
293
c SYS001 Systemic Lupus Erythematosus 87 0.484
294
NND010 Nondisjunction 34 0.484
295
PRX015 Paroxysmal Extreme Pain Disorder 56 0.484
296
PRP027 Peripheral Vascular Disease 71 0.484
297
c BSL026 Basal Cell Carcinoma 3 15 0.484
298
c BSL027 Basal Cell Carcinoma 4 13 0.484
299
DFC004 Deficiency Anemia 74 0.484
300
BRN032 Brain Glioma 45 0.484
301
ANG061 Angular Cheilitis 28 0.484
302
PLL012 Pollen Allergy 45 0.484
303
P CHN012 Chondrosarcoma 57 0.484
304
c SKN066 Skin/hair/eye Pigmentation, Variation in, 5 18 0.484
305
c FNC042 Fanconi Anemia, Complementation Group D2 54 0.484
306
PPL058 Papilloma of Choroid Plexus 55 0.484
307
IGR001 Ige Responsiveness, Atopic 59 0.484
308
c MLT160 Multiple Endocrine Neoplasia, Type Iia 67 0.484
309
c BSL024 Basal Cell Carcinoma 1 55 0.484
310
P STT056 Stature Quantitative Trait Locus 10 9 0.484
311
c STT057 Stature Quantitative Trait Locus 11 9 0.484
312
c STT058 Stature Quantitative Trait Locus 12 8 0.484
313
P MJR001 Major Depressive Disorder 68 0.484
314
c STT059 Stature Quantitative Trait Locus 13 8 0.484
315
c GLM038 Glioma Susceptibility 7 10 0.484
316
c GLM022 Glioma Susceptibility 8 10 0.484
317
c BSL028 Basal Cell Carcinoma 5 15 0.484
318
c BSL029 Basal Cell Carcinoma 6 13 0.484
319
c HRM007 Hermansky-Pudlak Syndrome 4 46 0.484
320
c ART152 Aortic Aneurysm, Familial Abdominal, 3 14 0.484
321
DRM014 Dermatofibrosarcoma Protuberans 65 0.484
322
c WLM005 Wilms Tumor 2 25 0.484
323
c THY109 Thyroid Cancer, Nonmedullary, 1 55 0.484
324
c TBR025 Tuberous Sclerosis 1 84 0.484
325
c SML038 Small Cell Cancer of the Lung 69 0.484
326
c HYP243 Hyperparathyroidism 1 47 0.484
327
HYP741 Hyperparathyroidism 2 with Jaw Tumors 51 0.484
328
c ANR027 Aneurysm, Intracranial Berry, 1 21 0.484
329
P CMP005 Campomelic Dysplasia 65 0.484
330
PLM129 Pulmonary Disease, Chronic Obstructive 74 0.484
331
JVN004 Juvenile Myelomonocytic Leukemia 67 0.484
332
P EST001 Estrogen-Receptor Positive Breast Cancer 49 0.484
333
GST019 Gastrointestinal Stromal Tumor 78 0.484
334
DSS032 Disease by Infectious Agent 55 0.484
335
TNG009 Tongue Squamous Cell Carcinoma 43 0.484
336
FBR054 Fibroma 44 0.484
337
P SLV026 Salivary Gland Carcinoma 58 0.484
338
MCS004 Mucosal Melanoma 46 0.484
339
BLY006 B-Lymphoblastic Leukemia/lymphoma with Hypodiploidy 31 0.484
340
NTM002 Nut Midline Carcinoma 44 0.484
341
P FML068 Familial Hypocalciuric Hypercalcemia 55 0.484
342
P LPS004 Lupus Erythematosus 61 0.484
343
SCT002 Scotoma 42 0.484
344
c ACT075 Acute Myocardial Infarction 56 0.484
345
MCP006 Mucoepidermoid Carcinoma 48 0.484
346
P FBR003 Fibrous Histiocytoma 43 0.484
347
SPR008 Supratentorial Primitive Neuroectodermal Tumor 42 0.484
348
PLX002 Plexiform Neurofibroma 43 0.484
349
ATY004 Atypical Neurofibroma 23 0.484
350
P CNT005 Central Nervous System Lymphoma 52 0.484
351
c MLG049 Malignant Syringoma 37 0.484
352
CRV002 Cervix Uteri Carcinoma in Situ 47 0.484
353
P PSR002 Psoriasis 63 0.484
354
P OSS001 Ossifying Fibroma 42 0.484
355
MNT002 Mental Depression 57 0.484
356
CRV038 Cervical Squamous Cell Carcinoma 58 0.484
357
P GST044 Gastritis 55 0.484
358
CLR018 Clear Cell Meningioma 30 0.484
359
PLS011 Plasmacytoma 56 0.484
360
PST011 Pustulosis of Palm and Sole 52 0.484
361
CLR030 Clear Cell Renal Cell Carcinoma 54 0.484
362
MNC006 Monoclonal Gammopathy of Uncertain Significance 47 0.484
363
CHL045 Choline Deficiency Disease 39 0.484
364
MYP002 Myoepithelial Carcinoma 46 0.484
365
P PLC011 Pilocytic Astrocytoma 57 0.484
366
P MNC007 Monocytic Leukemia 47 0.484
367
HLX001 Helix Syndrome 48 0.484
368
c ANR025 Aneurysm, Intracranial Berry, 10 11 0.484
369
c FTL070 Fetal Akinesia Deformation Sequence 2 36 0.484
370
THY006 Thymus Lymphoma 27 0.484
371
c DLT002 Dilated Cardiomyopathy 78 0.484
372
ALL029 Allergic Disease 59 0.484
373
SKN021 Skin Sarcoma 30 0.484
374
END041 Endometrial Adenocarcinoma 64 0.484
375
c MLG084 Malignant Fibrous Histiocytoma 62 0.484
376
CHL056 Cheilitis 46 0.484
377
GLS007 Glossitis 47 0.484
378
P BRS053 Breast Fibroadenoma 49 0.484
379
THR004 Thrombocytosis 53 0.484
380
P TBR001 Tuberous Sclerosis 69 0.484
381
P RSP003 Respiratory Failure 74 0.484
382
P PLY011 Polycystic Ovary Syndrome 57 0.484
383
GST029 Gastric Cardia Adenocarcinoma 29 0.484
384
SVR004 Severe Combined Immunodeficiency 72 0.484
385
PLS009 Plasma Cell Neoplasm 64 0.484
386
FBR086 Fibrolamellar Carcinoma 59 0.484
387
P PGT001 Paget's Disease of Bone 61 0.484
388
ECC004 Eccrine Porocarcinoma 42 0.484
389
c SPR009 Sporadic Breast Cancer 42 0.484
390
P GLL018 Gallbladder Cancer 53 0.484
391
DRM006 Dermatitis 62 0.484
392
NRL005 Neurilemmoma 60 0.484
393
P OVR049 Ovarian Disease 52 0.484
394
ACT200 Acute Monoblastic Leukemia 41 0.484
395
ORP003 Oropharynx Cancer 55 0.484
396
GRM010 Germ Cells Tumors 33 0.484
397
GLC036 Glucagonoma 46 0.484
398
P RCR004 Recurrent Respiratory Papillomatosis 48 0.484
399
SFT003 Soft Tissue Sarcoma 57 0.484
400
DPR016 Depression 65 0.484
401
CYT019 Cytogenetically Normal Acute Myeloid Leukemia 30 0.484
402
BLR013 Biliary Tract Cancer 43 0.484
403
CRV045 Cervical Intraepithelial Neoplasia 39 0.484
404
PRM128 Primary Cutaneous Follicle Center Lymphoma 22 0.484
405
FBR019 Fibromatosis 42 0.484
406
PPL060 Papillary Glioneuronal Tumors 21 0.484
407
PRM226 Primary Central Nervous System Lymphoma 47 0.484
408
c GLM047 Glioma Susceptibility 3 33 0.416
409
LNG111 Lung Non-Squamous Non-Small Cell Carcinoma 56 0.416
410
LNG115 Lung Sarcomatoid Carcinoma 36 0.416
411
c MSM022 Mismatch Repair Cancer Syndrome 1 70 0.416
412
c GLM025 Glioma Susceptibility 2 30 0.416
413
c GLM043 Glioma Susceptibility 9 30 0.416
414
LNG091 Lung Mucoepidermoid Carcinoma 32 0.416
415
CLL002 Collecting Duct Carcinoma 54 0.416
416
P LNG021 Lung Occult Small Cell Carcinoma 20 0.416
417
LNG003 Lung Carcinoma in Situ 36 0.416
418
BSL003 Basaloid Lung Carcinoma 35 0.416
419
LNG019 Lung Combined Type Small Cell Carcinoma 32 0.416
420
THY123 Thyroid Gland Follicular Carcinoma 55 0.416
421
P LNG035 Lung Large Cell Carcinoma 54 0.416
422
LNG011 Lung Adenoid Cystic Carcinoma 35 0.416
423
LNG020 Lung Oat Cell Carcinoma 51 0.416
424
LNG017 Lung Giant Cell Carcinoma 52 0.416
425
c LNG001 Lung Clear Cell Carcinoma 29 0.416
426
LNG006 Lung Occult Large Cell Carcinoma 14 0.416
427
LNG002 Lung Combined Large Cell Neuroendocrine Carcinoma 19 0.416
429
HLR002 Hilar Lung Carcinoma 24 0.416
430
LNG014 Lung Superior Sulcus Carcinoma 15 0.416
431
P ATS364 Autism 69 0.379
432
EWN003 Ewing Sarcoma 70 0.379
433
MYL005 Myelofibrosis 71 0.379
434
P EPL164 Epilepsy 68 0.379
435
TRN018 Transitional Cell Carcinoma 56 0.379
Content
Loading form....